Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease
- 1 December 1996
- journal article
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 81 (s25), 72S-80S
- https://doi.org/10.1111/j.1365-2672.1996.tb04835.x
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus rifampicinTubercle and Lung Disease, 1994
- Pyrazinamide Sterilizing ActivityIn Vitroagainst SemidormantMycobacterium tuberculosisBacterial PopulationsAmerican Review of Respiratory Disease, 1992
- The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosisTubercle and Lung Disease, 1992
- Is Pyrazinamide Bactericidal againstMycobacterium tuberculosis?American Review of Respiratory Disease, 1990
- Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254Antimicrobial Agents and Chemotherapy, 1989
- Five-Year Follow-Up of a Controlled Trial of Five 6-Month Regimens of Chemotherapy for Pulmonary TuberculosisAmerican Review of Respiratory Disease, 1987
- Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis second report: the results up to 24 monthsTubercle, 1982
- A controlled trial of six months chemotherapy in pulmonary tuberculosis: First report: Results during chemotherapyRespiratory Medicine, 1981
- Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis Second reportTubercle, 1980
- Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: The results up to 24 monthsTubercle, 1979